↓ Skip to main content

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?

Overview of attention for article published in Frontiers in Pharmacology, March 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
1 patent

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
Published in
Frontiers in Pharmacology, March 2021
DOI 10.3389/fphar.2021.633603
Pubmed ID
Authors

Ana Maria Oliveira Battastini, Fabricio Figueiró, Daniela Bitencourt Rosa Leal, Pedro Henrique Doleski, Maria Rosa Chitolina Schetinger

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 16%
Student > Bachelor 7 14%
Student > Ph. D. Student 6 12%
Student > Doctoral Student 3 6%
Other 2 4%
Other 6 12%
Unknown 18 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 22%
Medicine and Dentistry 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Engineering 3 6%
Immunology and Microbiology 3 6%
Other 5 10%
Unknown 21 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2024.
All research outputs
#8,820,267
of 26,187,546 outputs
Outputs from Frontiers in Pharmacology
#4,484
of 20,630 outputs
Outputs of similar age
#188,408
of 458,922 outputs
Outputs of similar age from Frontiers in Pharmacology
#184
of 703 outputs
Altmetric has tracked 26,187,546 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,630 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,922 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 703 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.